Results 221 to 230 of about 42,464 (273)

Oral Sildenafil in the Treatment of Erectile Dysfunction

50 Studies Every Urologist Should Know, 2021
This chapter summarizes the results of a landmark trial comparing different doses of oral sildenafil versus placebo to treat erectile dysfunction. Patients received either an identical placebo or 25- mg, 50-mg, or 100-mg tablets of sildenafil to be taken
J. Bodie
semanticscholar   +1 more source

Sildenafil

Journal of Sex & Marital Therapy, 1999
Case reports have documented the utility of sildenafil for sexual dysfunction caused by selective serotonin-reuptake inhibitors (SSRIs) and have suggested its potential utility for women and men with various iatrogenic sexual dysfunctions. This brief review summarizes the psychopharmacology of sildenafil, discusses possible interactions with SSRIs ...
J, Cartledge, I, Eardley
  +6 more sources

Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: Thinking about new indications

Fundamental & Clinical Pharmacology, 2020
Sildenafil, approved two decades ago, is the inhibitor of phosphodiesterase 5 (PDE5). First of all, it was designated for angina pectoris, but soon it showed a wonderful efficacy in erectile dysfunction (ED) and then pulmonary arterial hypertension (PAH).
Moein Ala   +2 more
semanticscholar   +1 more source

(Curcumin+sildenafil) enhances the efficacy of 5FU and anti‐PD1 therapies in vivo

Journal of Cellular Physiology, 2020
We have extended our analyses of (curcumin+sildenafil) biology. The drug combination caused vascularization and degradation of mutant K‐RAS that correlated with reduced phosphorylation of ERK1/2, AKT T308, mTORC1, mTORC2, ULK1 S757, STAT3, STAT5, and ...
P. Dent   +4 more
semanticscholar   +1 more source

Sildenafil ameliorates Alzheimer disease via the modulation of vascular endothelial growth factor and vascular cell adhesion molecule-1 in rats

Human and Experimental Toxicology, 2020
Alzheimer disease (AD) is a chronic neurodegenerative disease with multi-pathways pathogenesis. Sildenafil is a selective phosphodiesterase-5 inhibitor with a potential benefit in the treatment of AD.
MA Ibrahim   +3 more
semanticscholar   +1 more source

The Effect of Vaginal Sildenafil on The Outcome of Assisted Reproductive Technology Cycles in Patients with Repeated Implantation Failures: A Randomized Placebo-Controlled Trial

International Journal of Fertility and Sterility, 2019
Background The aim of this study was to investigate the effects of vaginal sildenafil on the outcome of patients with at least two unsuccessful in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) attempts.
A. Moini   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy